Updates
Alkem Laboratories Ltd has informed BSE regarding "Favourable Competition Appellate Tribunal Order - Penalty of Rs. 746.3 million set aside".10-05-2016
Updates
Alkem Laboratories Ltd has informed BSE regarding "Favourable Competition Appellate Tribunal Order - Penalty of Rs. 746.3 million set aside".Intimation of Conference Call on Q4 & FY16 Results
Alkem Laboratories Ltd has informed BSE regarding "Intimation of Conference Call on Q4 & FY16 Results".Alkem Laboratories nears to its lowest level since listing
The stock dipped 7% to Rs 1,236 on the BSE in early morning trade.Clarification
Alkem Laboratories Ltd has informed BSE that :"With respect to the recent news reports in the media in connection with 'Notification to the CHMP/EMA Secretariat of a Referral under Article 31 of Directive 2001/83/EC (the Directive) made by The Federal Institute of Drug and Medical Devices (BfArM) Germany. For the benefit of all the stakeholders, we would like to provide clarity on the issue as follows:...Alkem Labs accused of fudging trial data by German regulator
Alkem was found to have engaged in intentional misrepresentation' of data and duplicated results of ECG readings of patients in trials, the German regulator saidStatement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016
Alkem Laboratories Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.Shareholding for the Period Ended March 31, 2016
Alkem Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click hereAlkem Labs dips after observations from UK-MHRA
The company said that UK-MHRA has made eight observations following inspection of its Taloja facilityUK MHRA Inspection - Update
Alkem Laboratories Ltd has informed BSE about "UK MHRA Inspection - Update".Closure of Trading Window
Alkem Laboratories Ltd has informed BSE that in terms of Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the trading window will remain closed from March 30, 2016 until the expiry of 48 hours after the date on which the Financial Results of the Company for the quarter and year ended March 31, 2016 are communicated to the Stock Exchanges.